The Impact Of Musculoskeletal Disorders On An Australian Population
Funder
National Health and Medical Research Council
Funding Amount
$321,275.00
Summary
A significant proportion of the Australian population experiences pain and disability as a result of musculoskeletal disorders. This research examines a wide range factors related to these conditions and focuses on the knowledge of musculoskeletal disorders and the impact of musculoskeletal conditions on the population. The answers obtained from this research have the potential to positively and significantly impact on the lives of those with musculoskeletal conditions.
Novel Strategy For The Treatment Of Large Bone Defects Using A Unique Biomaterial With Tailored Microstructure
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
There is a rapidly increasing and pressing medical need for the development of synthetic implants that can regenerate large amounts of lost or diseased bone. This project will produce a unique implant with optimal mechanical and biological performance, which represents a viable alternative to bone grafting with broad applications for the repair of large or challenging bone defects. Such an achievement will produce significant healthcare benefits and improved long-term outcomes.
Investigating The Psychosocial And Socioeconomic Predictors Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$302,123.00
Summary
Osteoporosis is ranked the 7th national health priority, in recognition of the enormous impact on quality of life and greater risk of mortality following osteoporotic fracture. With few exceptions, socially disadvantaged individuals tend to have poorer health outcomes. However, little is known of psychosocial and socioeconomic determinants of osteoporosis, and barriers to preventive healthcare. This project will inform future health promotion messages targeted toward those most at risk.
The Effect Of Histone Deacetylase Inhibitors On The Bone Environment In Multiple Myeloma
Funder
National Health and Medical Research Council
Funding Amount
$356,899.00
Summary
Multiple myeloma (MM) is an incurable hematological malignancy with 1,400 people diagnosed each year. Severe bone loss occurs in up to 90% of these patientssignificantly impacting on quality of life resulting in severe bone pain and bone lesions that fail to heal. This project proposes that a novel histone deacetylase inhibitor could provide an appropriate therapeutic strategy that inhibits tumor growth and prevents bone loss whilst also promoting bone repair.